Tata Elxsi Ltd
₹3755
+38.20 (1.03%)
Fri, 06 Nov 2026, 09:59 pm
Tata Elxsi News
Tata Elxsi appoints Deloitte as statutory auditors
Tata Elxsi Board approves Deloitte Haskins & Sells as statutory auditors for five years, starting from the 38th AGM in 2027.
13 Oct 2026
companies
Tata Elxsi Q2 profit flat at ₹1.7B; misses est
Tata Elxsi reported Q2 net profit of ₹1.7 billion, flat YoY and below the ₹1.8 billion estimate. Revenue rose to ₹10.56 billion QoQ, with EBIT margin expanding to 19.68%.
13 Oct 2026
companies
Tata Elxsi sets Q2 FY27 earnings call for Oct 13
Tata Elxsi Limited will announce its financial results for the quarter and half-year ended September 30, 2026, on October 13. An investors' conference call is scheduled for 7:00 pm IST.
06 Oct 2026
companies
Tata Elxsi to host analyst meet on Sep 22
Tata Elxsi Limited will participate in the J.P. Morgan India Conference in Mumbai on September 22, 2026. The physical group meeting is scheduled under SEBI Regulation 30.
17 Sept 2026
companies
Tata Elxsi invests in Kavia AI for AI software engineering
Tata Elxsi has invested in Kavia AI to boost AI software engineering, enhance collaboration for modern software systems, and target faster AI development.
10 Sept 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo